USPTO serial 99063919
NEURALINK
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- STEEL, ALYSSA PALADINO
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with NEURALINK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $449*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Fremont, CA, US
Fremont, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John M. Kim
John M. Kim IPLA, LLP4445 Eastgate MallSuite 200San Diego, CA 92121Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable and recorded software as a medical device (SaMD) for treating, monitoring, and analyzing neurological, psychiatric, and nervous system disorders and conditions in the medical field; downloadable and recorded computer software for use in relation to treating, monitoring, and analyzing neurological, psychiatric, and nervous system disorders and conditions in the medical field; downloadable and recorded computer software for treating, monitoring, and analyzing brain neuroactivity; downloadable and recorded computer software and hardware for treating, monitoring, and analyzing neurological, psychiatric, and nervous system disorders and conditions for use in relation to restoring visual perception; downloadable software for processing and visualizing neural signals; downloadable and recorded computer software and hardware for treating, monitoring, and analyzing neurological, psychiatric, and nervous system disorders and conditions for use in relation to operating medical assistive technology; downloadable and recorded computer software and hardware for treating, monitoring, and analyzing neurological, psychiatric, and nervous system disorders and conditions for use in relation to the treatment and restoration of visual perception; downloadable and recorded computer software and hardware for use in treating or diagnosing neurological conditions; downloadable and recorded computer software and hardware operating as an interface between the brain, computer hardware and software systems or assistive technology devices; downloadable software as a medical device (SaMD) for treating, monitoring, and analyzing neurological, psychiatric, and nervous system disorders and conditions; scientific instrumentation for measuring, recording, analyzing and storing neural signals not for medical use; downloadable software for processing and visualizing electrical and neural signals; downloadable and recorded software applications for use with mobile devices or a computer for monitoring and managing brain computer interface connected devices; downloadable and recorded software applications for monitoring and managing patient medical information; medical simulators for use in relation to treating, monitoring, and analyzing neurological, psychiatric, and nervous system disorders and conditions; scientific and medical data downloadable via the internet; downloadable and recorded computer software for use in operating medical decision support systems (MDSS); downloadable computer programs using machine learning in the fields of neuroscience, assistive technology, vision perception and ophthalmology for use in treating, monitoring, and analyzing neurological, psychiatric, and nervous system disorders and conditions; downloadable computer programs using artificial intelligence in the fields of neuroscience, assistive technology, vision perception and ophthalmology for use in treating, monitoring, and analyzing neurological, psychiatric, and nervous system disorders and conditions; battery chargers; portable power chargers; wireless chargers | ACTIVE | — |
| 010 | Surgical robots; medical apparatus for use in treating or diagnosing neurological, psychiatric, and nervous system disorders and conditions; medical devices for use in treating or diagnosing neurological, psychiatric, and nervous system disorders and conditions; medical robots for use in neurosurgery; medical apparatus for use in neurosurgery; robotic medical apparatus, for the insertion of implants into the brain; surgical and medical devices in relation to assistive technology for use in treating, monitoring, and analyzing neurological, psychiatric, and nervous system disorders and conditions; medical devices being electrodes for use as a brain computer interface; surgical and medical devices for use in medical treatment of physical paralysis; surgical and medical devices for use in restoring visual perception and functions; surgical devices for implanting brain computer interface and cortical implants; medical devices being electrodes for use in facilitating communication and body control through the use of embedded interface software and hardware therefor; medical devices namely, an implantable brain to computer interface for facilitating human communication and control of software and hardware; surgical and medical devices for use in facilitating human communication, movement, sensory and visual functions; surgical and medical devices namely, an implantable brain to computer interface for restoring communication, movement, sensory and visual functions; medical devices for neural signal processing; medical electrodes; medical implants for use in the brain comprising or primarily comprising artificial material; electrotherapeutic medical devices, namely, electric neurostimulation devices for restoring visual perception; cortical implants; cortical electrodes being medical electrodes; medical apparatus and instruments, namely, microchips, electrodes, and electronics for processing neural signals for medical purposes; component parts and fittings for all the aforesaid goods | ACTIVE | — |
| 042 | Software as a service (SaaS) services featuring software that provides an interface between the brain and computer systems to allow users to control external devices | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 18, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 14, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 14, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 14, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 17, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 20, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 20, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 14, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 19, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 19, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 19, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 19, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 19, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 12, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 11, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 11, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 30, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 30, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 30, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 30, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 30, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 30, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 7, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 7, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 7, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 7, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 6, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 3, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 3, 2025 | NWAP | NEW APPLICATION ENTERED | — |